Using tDCS (mild brain stimulation) to reduce vaping
Official title: Using Transcranial Direct Current Stimulation (tDCS) for Vaping Reduction in Daily E-cigarette Users: a Pilot Study
Run by Centre for Addiction and Mental Health · NCT06885606 · Data updated 2026-11-12
This project will try daily transcranial direct current stimulation (tDCS) to reduce cravings and vaping in adults who use nicotine e-cigarettes every day and are not planning to quit.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | April 2026 |
| Study ends | May 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT06885606 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–65 who vape nicotine daily for at least six months, are not planning to quit in the next 30 days, can provide consent, and can attend daily clinic visits for two weeks.
✕Probably not a fit
People with other substance use disorders, current cigarette smokers or nicotine-replacement users, unstable psychiatric illness, a history of seizures, or those seeking immediate quit treatment may not receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–65 who have used nicotine e-cigarettes daily for at least six months and are not planning to quit will be enrolled at the Centre for Addiction and Mental Health in Toronto. Participants will receive either active tDCS or sham (placebo) tDCS and will attend daily stimulation sessions Monday through Friday for two consecutive weeks. The study will measure changes in vaping craving and behavior around the stimulation period. People with other substance use disorders, current tobacco or nicotine-replacement use, unstable psychiatric conditions, recent significant head trauma, or seizure history are excluded.
Why it matters
Potential benefit: If successful, this approach could reduce e-cigarette cravings and help some people cut down or stop vaping using a brief, low-cost noninvasive treatment.
How similar studies have gone: Prior tDCS studies have shown mixed but sometimes promising reductions in craving for nicotine and other substances, though specific evidence for vaping is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The participant must meet all of the inclusion criteria to be eligible for this research study: 1. Be able to provide informed written consent 2. Stated willingness to comply with all study procedures 3. Age 18 - 65 years 4. Is a daily regular use of nicotine-containing e-cigarette for at least the past 6 months 5. Is willing to attend daily appointments for tDCS for two consecutive weeks (Monday through Friday) 6. Is not interested in or planning to quit vaping in the next 30 days. Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this research study: 1. Substance use disorder (other than nicotine dependence) (M.I.N.I. SCID) (confirmed with urine drug screen) 2. Current regular use of tobacco cigarettes, nicotine replacement therapy or other medications for smoking cessation 3. Unstable psychiatric condition 4. Recent clinically significant head trauma\* 5. History of seizures and/or epilepsy\* 6. Pacemakers or implanted electrical devices such as cochlear implants\* 7. Metal embedded in the skull\* 8. Skin lesions, open wounds, bruising, or similar injuries on the scalp\*
Where it's running
-
Centre for Addiction and Mental Health
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Eunice Chen, M.Sc.
- Email: yixuan.chen@camh.ca
- Phone: (416) 535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vocal Signals of Craving in Addiction
Researchers will see if voice patterns can signal craving in adults with addictions by having them perform voice tasks and report their cravings in real time.
-
Impact of GLP-1 Receptor Agonist Therapy vs Structured Lifestyle on Weight and Health
This study tests whether starting a GLP-1 receptor agonist for weight loss works differently from a structured diet-and-exercise program in improving heart and metabolic health for adults with overweight or obesity.
-
Craving and addiction severity: how craving links to changing levels of addiction in daily life
This observational study tests whether craving and the way different addiction symptoms interact can predict changes in addiction severity over two years for adults with substance use disorders.
-
Mobile phone use restriction and PET imaging of dopamine transporter
This study tests how restricting daily mobile phone use for two weeks affects dopamine transporter binding in healthy iPhone users who can use the Screentime app.
-
STAR Project: Supporting Recovery for People with Criminal Legal System Involvement
A new coaching program tests whether paired Recovery Coach and Loved One Coach sessions help people in recovery from substance use and their supporters see better recovery outcomes.
-
NLP-based weekly writings to track mood and worry during residential rehab for SUD
This study tests whether weekly Spanish narratives and biweekly questionnaires can reveal patterns of mood and thoughts that relate to recovery in adults with substance use disorders in a Mexican rehab center.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.